Although the role of PTEN expression/function in CSC needs to be studied in more detail, here we show that combined MEK/mTOR inhibition exerts synergistic anti-tumor activity in vitro and, most importantly, in vivo, in a proportion of lung and colorectal CSC-derived models. This evidence concerns the gene MTOR and neoplasm.